Compare RKLB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKLB | BNTX |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6B | 24.8B |
| IPO Year | N/A | 2019 |
| Metric | RKLB | BNTX |
|---|---|---|
| Price | $53.68 | $91.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $50.38 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 20.3M | 1.4M |
| Earning Date | 11-10-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $554,535,000.00 | ★ $3,698,814,972.00 |
| Revenue This Year | $40.19 | $2.36 |
| Revenue Next Year | $48.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 52.42 | 3.70 |
| 52 Week Low | $14.71 | $81.20 |
| 52 Week High | $73.97 | $129.27 |
| Indicator | RKLB | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 32.13 |
| Support Level | $52.68 | $94.52 |
| Resistance Level | $65.18 | $97.35 |
| Average True Range (ATR) | 4.14 | 2.33 |
| MACD | 1.36 | -0.42 |
| Stochastic Oscillator | 54.90 | 2.64 |
Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.